BRPI0516253A - vacinas caninas multivalentes contra leptospira bratislava e outros patógenos - Google Patents
vacinas caninas multivalentes contra leptospira bratislava e outros patógenosInfo
- Publication number
- BRPI0516253A BRPI0516253A BRPI0516253-0A BRPI0516253A BRPI0516253A BR PI0516253 A BRPI0516253 A BR PI0516253A BR PI0516253 A BRPI0516253 A BR PI0516253A BR PI0516253 A BRPI0516253 A BR PI0516253A
- Authority
- BR
- Brazil
- Prior art keywords
- canine
- caused
- leptospira
- pathogens
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/175—Canine distemper virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/235—Adenoviridae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14311—Parvovirus, e.g. minute virus of mice
- C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
VACINAS CANINAS MULTIVALENTES CONTRA LEPTOSPIRA BRATISLAVA E OUTROS PATóGENOS. A invenção relaciona-se a vacinas e métodos para proteção de cachorros contra doença causada por Leptospira bratislava. Esta invenção também se relaciona a combinação de vacinas e métodos para proteger cachorros contra doença ou desordem causada por patógenos, por exemplo, infecções traqueobronquites cansadas por Bordetella bronchiseptica, cinomose canina causada por vírus da cinomose canina (CC), infecção de hepatite canina (IHC) causada por adenovírus canino do tipo 1 (ACT-1), doença respiratória causada por adenovírus canino tipo 2 (ACT-2), parainfluenza canina causada por vírus parainfluenza canina (PIC), enterite causada por coronavírus canino (CVC) e parvovírus canino (PVC), e leptospirose causada por Leptospira bratislava, Leptospira canicola, Leptospira grippotyphosa, Leptospira icterohaemorrahagiae ou Leptospira pomona.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/959,757 US20050089533A1 (en) | 2003-01-29 | 2004-10-06 | Canine vaccines against Bordetella bronchiseptica |
PCT/IB2005/003111 WO2006038115A1 (en) | 2004-10-06 | 2005-09-23 | Multivalent canine vaccines against leptospira bratislava and other pathogens |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0516253A true BRPI0516253A (pt) | 2008-08-26 |
Family
ID=35657262
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0516253-0A BRPI0516253A (pt) | 2004-10-06 | 2005-09-23 | vacinas caninas multivalentes contra leptospira bratislava e outros patógenos |
Country Status (26)
Country | Link |
---|---|
US (2) | US20050089533A1 (pt) |
EP (1) | EP1799253B1 (pt) |
JP (2) | JP4163245B2 (pt) |
KR (3) | KR20070050499A (pt) |
CN (2) | CN101035558B (pt) |
AT (1) | ATE524193T1 (pt) |
AU (1) | AU2005290921C1 (pt) |
BR (1) | BRPI0516253A (pt) |
CA (1) | CA2583689C (pt) |
CY (1) | CY1114897T1 (pt) |
DK (1) | DK1799253T3 (pt) |
ES (1) | ES2370750T3 (pt) |
HK (1) | HK1112839A1 (pt) |
LU (2) | LU92135I2 (pt) |
ME (1) | ME01306B (pt) |
MX (1) | MX2007004133A (pt) |
NO (1) | NO20071385L (pt) |
NZ (3) | NZ591422A (pt) |
PL (1) | PL1799253T3 (pt) |
PT (1) | PT1799253E (pt) |
RS (1) | RS52035B (pt) |
RU (1) | RU2400248C2 (pt) |
SI (1) | SI1799253T1 (pt) |
UA (1) | UA91197C2 (pt) |
WO (1) | WO2006038115A1 (pt) |
ZA (1) | ZA200702166B (pt) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050089533A1 (en) * | 2003-01-29 | 2005-04-28 | Joseph Frantz | Canine vaccines against Bordetella bronchiseptica |
ME00485B (me) * | 2005-10-07 | 2011-10-10 | Zoetis Services Llc | VAKCINE l METODE LIJEČENJA INFLUENCE KOD CANINA |
US7468187B2 (en) * | 2005-10-18 | 2008-12-23 | Iowa State University Research Foundation, Inc. | Canine influenza virus and related compositions and methods of use |
US7682619B2 (en) * | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
EP2062972A4 (en) * | 2006-09-13 | 2010-11-24 | Nippon Zenyaku Kogyo Co Ltd | NEW DOG VACCINE |
MX2009004866A (es) * | 2006-11-03 | 2009-05-19 | Schering Plough Ltd | Vacuna para enfermedad de lyme canina. |
US20100028379A1 (en) * | 2006-12-27 | 2010-02-04 | Pfizer, Inc | Methods of vaccine administration |
AU2015255165A1 (en) * | 2006-12-27 | 2015-11-26 | Zoetis Services Llc | Methods of vaccine administration |
JP5470052B2 (ja) | 2007-02-27 | 2014-04-16 | ゾエティス・ダブリュー・エルエルシー | 動物の感染症を治療または予防するための免疫原組成物 |
US7878586B2 (en) * | 2007-10-29 | 2011-02-01 | The Boeing Company | System and method for an anticipatory passenger cabin |
CA2710186C (en) | 2007-12-21 | 2015-11-03 | Pfizer Inc. | Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins |
CA2777692A1 (en) | 2009-10-14 | 2011-04-21 | Sanjay Kapil | Isolation of a virus related to canine parvovirus-2 from a raccoon |
CN103153337A (zh) | 2010-09-28 | 2013-06-12 | 共立制药股份有限公司 | 黏膜佐剂组合物 |
CA2826058C (en) * | 2011-02-04 | 2017-06-06 | Zoetis Llc | Compositions for canine respiratory disease complex |
PL2670432T3 (pl) * | 2011-02-04 | 2021-10-11 | Zoetis Services Llc | Kompozycje immunogenne Bordetella bronchiseptica |
CN102343088B (zh) * | 2011-10-14 | 2013-02-13 | 浙江诺倍威生物技术有限公司 | 一种犬传染性气管支气管炎二联活疫苗及其制备方法 |
BR112015003074A2 (pt) | 2012-08-17 | 2017-07-04 | Intervet Int Bv | composição, vacina para proteger um animal contra uma infecção com bactérias leptospira, e, uso de ácido etilenodiaminatetra-acético. |
AU2013304048B2 (en) * | 2012-08-17 | 2018-03-01 | Intervet International B.V. | An immunogenic composition of killed Leptospira bacteria |
US9314519B2 (en) * | 2012-08-21 | 2016-04-19 | Intervet Inc. | Liquid stable virus vaccines |
CZ307883B6 (cs) * | 2013-01-29 | 2019-07-24 | Bioveta, A.S. | Multivalentní vakcína k imunoprofylaxi infekčních onemocnění psů |
RU2546247C2 (ru) * | 2013-06-06 | 2015-04-10 | Автономная некоммерческая организация "Научно-исследовательский институт диагностики и профилактики болезней человека и животных" (АНО "НИИ ДПБ") | Вакцина против чумы, аденовирусных инфекций, парвовирусного и коронавирусного энтеритов, лептоспироза и бешенства собак |
KR101622554B1 (ko) | 2014-07-16 | 2016-05-19 | (주)양성그린바이오 | 면역항체를 이용한 강아지질병의 치료용 조성물의 제조방법 |
EP3909971A1 (en) | 2020-09-28 | 2021-11-17 | Institute of Life Sciences (ILS) | Whole cell livestock vaccine for respiratory diseases |
CN117187118A (zh) * | 2023-08-16 | 2023-12-08 | 华中农业大学 | 一株支气管败血波氏杆菌a1218及其应用 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3470294A (en) * | 1961-06-21 | 1969-09-30 | Behringwerke Ag | Vaccine for immunization of dogs and foxes against distemper,hepatitis contagiosa and leptospirosis and process for preparing it |
US4567042A (en) * | 1983-06-15 | 1986-01-28 | American Home Products Corporation | Inactivated canine coronavirus vaccine |
US4567043A (en) * | 1983-06-15 | 1986-01-28 | American Home Products Corporation (Del.) | Canine corona virus vaccine |
US4888169A (en) * | 1986-10-14 | 1989-12-19 | Norden Laboratories, Inc. | Bordetella Bronchiseptica vaccine |
JP2521226B2 (ja) * | 1993-01-28 | 1996-08-07 | 株式会社微生物化学研究所 | 犬用多種混合ワクチン |
ATE224202T1 (de) * | 1993-03-31 | 2002-10-15 | Univ California | Cloniertes protein der äusseren membran von leptospira |
UA56132C2 (uk) * | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
AUPO549497A0 (en) * | 1997-03-07 | 1997-03-27 | Agriculture Victoria Services Pty Ltd | Novel bacterial pathogens |
US6306623B1 (en) * | 1998-02-24 | 2001-10-23 | The University Of California | Leptospiral major outer membrane protein LipL32 |
NZ501213A (en) * | 1998-12-22 | 2001-09-28 | Pfizer Prod Inc | Isolated leptospira membrane kinase, membrane permease, membrane mannosyltransferase and endoflagellin proteins for preventing leptospirosis |
US20020058039A1 (en) * | 2000-04-27 | 2002-05-16 | Coyne Michael J. | Method of measuring the duration of adequate immune memory in companion animals |
US20030129161A1 (en) * | 2001-09-17 | 2003-07-10 | Hsien-Jue Chu | Interleukin-12 as a veterinary vaccine adjuvant |
AU2002308453B2 (en) * | 2002-05-17 | 2009-12-03 | Fundacao Oswaldo Cruz-Fiocruz | Proteins with repetitive Bacterial-Ig-like (Big) domains present in Leptospira species |
OA12915A (en) * | 2002-08-26 | 2006-10-13 | Pfizer Prod Inc | Vaccine for respiratory and reproductive system infections in cattle. |
BRPI0407032A (pt) * | 2003-01-29 | 2006-01-17 | Pfizer Prod Inc | Vacinas caninas contra bordetella bronchiseptica |
US20050089533A1 (en) * | 2003-01-29 | 2005-04-28 | Joseph Frantz | Canine vaccines against Bordetella bronchiseptica |
US20100028379A1 (en) * | 2006-12-27 | 2010-02-04 | Pfizer, Inc | Methods of vaccine administration |
-
2004
- 2004-10-06 US US10/959,757 patent/US20050089533A1/en not_active Abandoned
-
2005
- 2005-09-23 NZ NZ591422A patent/NZ591422A/xx not_active Application Discontinuation
- 2005-09-23 AT AT05789769T patent/ATE524193T1/de active
- 2005-09-23 WO PCT/IB2005/003111 patent/WO2006038115A1/en active Application Filing
- 2005-09-23 NZ NZ576898A patent/NZ576898A/en not_active Application Discontinuation
- 2005-09-23 CN CN2005800341946A patent/CN101035558B/zh active Active
- 2005-09-23 JP JP2007535271A patent/JP4163245B2/ja active Active
- 2005-09-23 NZ NZ553867A patent/NZ553867A/en not_active Application Discontinuation
- 2005-09-23 DK DK05789769.6T patent/DK1799253T3/da active
- 2005-09-23 MX MX2007004133A patent/MX2007004133A/es active IP Right Grant
- 2005-09-23 RU RU2007112480/13A patent/RU2400248C2/ru active
- 2005-09-23 BR BRPI0516253-0A patent/BRPI0516253A/pt not_active Application Discontinuation
- 2005-09-23 PL PL05789769T patent/PL1799253T3/pl unknown
- 2005-09-23 ME MEP-2011-192A patent/ME01306B/me unknown
- 2005-09-23 ES ES05789769T patent/ES2370750T3/es active Active
- 2005-09-23 UA UAA200703828A patent/UA91197C2/ru unknown
- 2005-09-23 AU AU2005290921A patent/AU2005290921C1/en not_active Expired
- 2005-09-23 SI SI200531376T patent/SI1799253T1/sl unknown
- 2005-09-23 KR KR1020077008111A patent/KR20070050499A/ko not_active Application Discontinuation
- 2005-09-23 KR KR1020127000574A patent/KR101226869B1/ko active IP Right Grant
- 2005-09-23 CN CN200910226561A patent/CN101791398A/zh active Pending
- 2005-09-23 KR KR1020087025748A patent/KR20080096610A/ko not_active Application Discontinuation
- 2005-09-23 EP EP05789769A patent/EP1799253B1/en active Active
- 2005-09-23 RS RS20110497A patent/RS52035B/en unknown
- 2005-09-23 PT PT05789769T patent/PT1799253E/pt unknown
- 2005-09-23 CA CA2583689A patent/CA2583689C/en active Active
-
2007
- 2007-03-14 ZA ZA200702166A patent/ZA200702166B/xx unknown
- 2007-03-15 NO NO20071385A patent/NO20071385L/no unknown
- 2007-12-21 US US11/962,699 patent/US20080175860A1/en not_active Abandoned
-
2008
- 2008-02-22 HK HK08101940.1A patent/HK1112839A1/xx unknown
- 2008-04-15 JP JP2008105332A patent/JP2008239627A/ja active Pending
-
2011
- 2011-10-17 CY CY20111100986T patent/CY1114897T1/el unknown
-
2013
- 2013-01-16 LU LU92135C patent/LU92135I2/fr unknown
- 2013-01-16 LU LU92136C patent/LU92136I2/fr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0516253A (pt) | vacinas caninas multivalentes contra leptospira bratislava e outros patógenos | |
TW200505476A (en) | Canine vaccines against bordetella bronchiseptica | |
HRP20090271A2 (en) | Vaccine for respiratory and reproductive system infections in cattle | |
IL131678A0 (en) | An immunological composition comprising a borrelia burgdorferi antigen and its use | |
WO2004096993A3 (en) | Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus | |
WO2004093904A3 (en) | Modified live vaccines comprising bhv-1(ibr) and/or bvdv pregnant and nursing cattles | |
McFarland et al. | Non-animal replacement methods for human vaccine potency testing: state of the science and future directions | |
BRPI0407436A (pt) | Composições adesivas para dentaduras, bem como método para a obtenção de efeito antiplaca | |
AR070675A1 (es) | Bacterinas tratadas termicamente y vacunas de emulsion preparadas a partir de tales bacterinas tratadas termicamente | |
WO2008106393A3 (en) | Immunogenic compositions and methods for treating and preventing animal infections | |
PT784486E (pt) | Inerleucina-12 como um adjuvante para vacinas contra paramyxoviridae | |
Gingerich et al. | Intranasal vaccine for Lyme disease provides protection against tick transmitted Borrelia burgdorferi beyond one year | |
Casal | How have vaccines changed the incidence of infectious diseases? | |
AR045152A1 (es) | Vacunas virales mutantes | |
TH94300A (th) | องค์ประกอบก่อภูมิคุ้มกัน pcv2 ชนิดมัลติเวเลนต์ และวิธีของการผลิตองค์ประกอบเหล่านี้ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: PAH USA 15 LLC (US) |
|
B25D | Requested change of name of applicant approved |
Owner name: ZOETIS P LLC (US) |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 11, 13, 25, 10 DA LPI |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |